Spain Cardiovascular Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Spain Cardiovascular Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Indication (Coronary Artery Disease, Arrhythmia, Heart Failure, Valvular Heart Disease), End User (Hospitals, Home Care Settings, Others), and Geography (Spain). The Market Forecasts are Provided in Terms of Value (USD).

Spain Cardiovascular Devices Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
View Global Report

Compare market size and growth of Spain Cardiovascular Devices Market with other markets in Healthcare Industry

Spain Cardiovascular Devices Market Analysis by Mordor Intelligence

The Spain cardiovascular devices market size stands at USD 1.55 billion in 2025 and is projected to reach USD 2.01 billion by 2030, yielding a compound annual growth rate (CAGR) of 5.39% for 2025-2030. This growth reflects the government’s effort to modernize public hospital equipment while maintaining overall budget discipline. Therapeutic and surgical devices command the largest Spain cardiovascular devices market share, whereas diagnostic and monitoring technologies are advancing faster as hospitals look to detect disease earlier and shorten inpatient stays. Manufacturers that bundle interventional hardware with digital monitoring services already benefit from broader recurring revenue streams. Meanwhile, accelerated investment by private cardiology networks lifts total demand and raises expectations for premium functionality, forcing suppliers to balance standardized offerings for public institutions with high-end solutions for private centers.

Key Report Takeaways

By device type, therapeutic and surgical products led with 57.20% of Spain cardiovascular devices market share in 2024; diagnostic and monitoring equipment is forecast to expand at a 6.03% CAGR to 2030.  

By indication, coronary artery disease accounted for 55.21% of the Spain cardiovascular devices market size in 2024, while valvular heart disease is set to grow at a 6.84% CAGR through 2030.  

By end user, hospitals controlled 68.20% of revenue in 2024; home-care settings are projected to post the fastest growth at a 7.11% CAGR between 2025-2030. 

Segment Analysis

By Device Type: Diagnostic Momentum Beside Therapeutic Scale

Therapeutic and surgical devices held 57.20% of Spain cardiovascular devices market share in 2024, buoyed by coronary stents and cardiac rhythm-management implants. Concurrently, the Spain cardiovascular devices market size for diagnostic and monitoring equipment is expected to grow at 6.03% CAGR through 2030 thanks to AI-guided imaging and national funding for early detection. Advanced transcatheter tools also shorten the life cycle of older surgical devices, shifting procurement toward minimally invasive systems that shorten hospital stays. Vendors that can package modular software licenses with core hardware capture incremental revenue without proportionally higher production costs.

Diagnostic adoption is no longer confined to academic centers. Fractional flow-reserve platforms and 3D echocardiography are penetrating regional hospitals, encouraged by standardized procurement guidelines under the National Cardiovascular Health Plan. At the same time, the therapeutic segment is intensifying its focus on structural heart interventions as payers recognize the cost benefits of shorter recovery times. Hospitals that achieve lower length-of-stay metrics through device innovation often qualify for performance-based financing, bolstering demand for the latest implants.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

By Indication: Coronary Dominance With Valvular Acceleration

The Spain cardiovascular devices market size allocated to coronary artery disease reached 55.21% in 2024, reflecting mature infrastructure and clinician expertise. Drug-eluting stent iterations and imaging-guided angioplasty deliver steady incremental value. Suppliers mitigate price pressure by bundling low-margin consumables with proprietary analytics. Valvular heart disease, while smaller, is positioned for a 6.84% CAGR during 2025-2030 following expanded TAVR and TMVR reimbursement. Hospitals that field dedicated heart teams already capture rising referral volumes, indicating that procedural capacity can determine future share more than device availability.

Heart-failure management and electrophysiology are gaining visibility. Implantable hemodynamic monitors furnish real-time data that prevent decompensation events, trimming readmissions. Catheter ablation volumes grew 18% in 2024, demonstrating that arrhythmia therapy is spreading beyond tertiary centers. Vendors integrating mapping systems with ablation hardware provide single-source solutions that many hospitals view as operationally advantageous.

Geography Analysis

Madrid and Catalonia accounted for close to one-third of Spain cardiovascular devices market size in 2024, supported by dense networks of tertiary hospitals and vibrant clinical research programs. Capital budgets in these regions favor AI-enabled imaging and advanced electrophysiology, cementing their status as early adopters. Valencia and Andalusia, constrained by stringent price caps, often defer premium purchases or rely on multi-year leasing to introduce new technologies.

Northern provinces such as Galicia and Asturias demonstrate rising need for cardiac rhythm-management implants as their ageing populations exceed the national mean. Grants from the National Cardiovascular Health Plan financed the first catheterization labs in several of these areas, cutting patient travel times and boosting local procedure volumes. Vendors that situate service hubs near these new centers can lock in early loyalty.

Along the Mediterranean coast, seasonal tourism spikes stretch interventional capacity. Hospitals in Murcia and Alicante deploy modular cath-lab layouts and portable imaging to manage fluctuating demand. Evening TAVR sessions free daytime capacity for emergent cases, pointing to ongoing demand for consumables even during periods traditionally considered low-utilization. Suppliers capable of rapid restocking gain an advantage in these time-sensitive settings.

Competitive Landscape

The five largest manufacturers secured more than 50% Spain cardiovascular devices market share in 2024, resulting in moderate market concentration. Broad-line suppliers leverage integrated portfolios to win system-wide contracts that bundle implants, imaging, analytics, and maintenance. Niche innovators succeed by excelling in specialized segments such as drug-coated balloons or implantable loop recorders, often collaborating with academic hospitals to develop evidence for superior outcomes.

Strategic alliances with leading cardiac centers accelerate device refinement. Early access trials allow hospitals to shape iterative design, while vendors collect real-world performance data for regulatory filings. These collaborations underscore that future share battles may hinge more on clinical proof than on headline pricing alone.

Digital integration represents the new competitive frontier. Manufacturers combining hardware with cloud-based decision support embed themselves deep within hospital IT architecture. Patent activity in predictive analytics surged during 2024, indicating a race to control the data layer of cardiovascular care. Platforms offering open APIs could outpace closed ecosystems as health networks increasingly prioritize interoperability.

Spain Cardiovascular Devices Industry Leaders

  1. Boston Scientific Corporation

  2. Cardinal Health

  3. Siemens Healthineers

  4. Medtronic

  5. Abbott

  6. *Disclaimer: Major Players sorted in no particular order
Spain Cardiovascular Devices Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • April 2025: Spanish cardiology societies issued gender-specific cardiovascular guidelines, prompting hospitals to adjust imaging protocols for women
  • March 2025: Philips rolled out its ePatch wearable ECG and AI analytics to 14 Spanish hospitals, enabling 14-day continuous monitoring

Table of Contents for Spain Cardiovascular Devices Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 National Cardiovascular Health Plan 2022-2029 Catalyzing Device Procurement in Public Hospitals
    • 4.2.2 Rapidly Ageing Spanish Population Expanding Cardiac Device Demand
    • 4.2.3 Reimbursement of TAVR & TMVR Accelerating Structural Heart Device Uptake
    • 4.2.4 Expansion of Private Cardiology Networks Driving High-End CRM & Imaging Equipment
    • 4.2.5 Rising Funds for Digital Cardiac Tele-monitoring Platforms
  • 4.3 Market Restraints
    • 4.3.1 Regional Tender Price-Caps Compressing Average Selling Prices
    • 4.3.2 MDR Recertification Backlog Delaying New Product Launches in Spain
    • 4.3.3 Shortage of Interventional Cardiologists Outside Madrid & Catalonia Limiting Procedure Volumes
    • 4.3.4 120-Day Hospital Payment Cycles Impacting Vendor Cash-Flow
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts

  • 5.1 By Device
    • 5.1.1 Diagnostic & Monitoring Devices
    • 5.1.1.1 ECG Systems
    • 5.1.1.2 Remote Cardiac Monitor
    • 5.1.1.3 Cardiac MRI
    • 5.1.1.4 Cardiac CT
    • 5.1.1.5 Echocardiography / Ultrasound
    • 5.1.1.6 Fractional Flow Reserve (FFR) Systems
    • 5.1.2 Therapeutic & Surgical Devices
    • 5.1.2.1 Coronary Stents
    • 5.1.2.1.1 Drug-Eluting Stents
    • 5.1.2.1.2 Bare-Metal Stents
    • 5.1.2.1.3 Bioresorbable Stents
    • 5.1.2.2 Catheters
    • 5.1.2.2.1 PTCA Balloon Catheters
    • 5.1.2.2.2 IVUS/OCT Catheters
    • 5.1.2.3 Cardiac Rhythm Management
    • 5.1.2.3.1 Pacemakers
    • 5.1.2.3.2 Implantable Cardioverter Defibrillators
    • 5.1.2.3.3 Cardiac Resynchronization Therapy Devices
    • 5.1.2.4 Heart Valves
    • 5.1.2.4.1 TAVR/TAVI
    • 5.1.2.4.2 Mechanical Valves
    • 5.1.2.4.3 Tissue/Bioprosthetic Valves
    • 5.1.2.5 Ventricular Assist Devices
    • 5.1.2.6 Artificial Hearts
    • 5.1.2.7 Grafts & Patches
    • 5.1.2.8 Other Cardiovascular Surgical Devices
  • 5.2 By Indication
    • 5.2.1 Coronary Artery Disease
    • 5.2.2 Arrhythmia
    • 5.2.3 Heart Failure
    • 5.2.4 Valvular Heart Disease
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Home care Settings
    • 5.3.3 Others

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
    • 6.3.1 Medtronic Plc
    • 6.3.2 Boston Scientific Corporation
    • 6.3.3 Abbott Laboratories
    • 6.3.4 Edwards Lifesciences Corporation
    • 6.3.5 Philips Healthcare
    • 6.3.6 Siemens Healthineers AG
    • 6.3.7 Terumo Corporation
    • 6.3.8 Biotronik SE & Co. KG
    • 6.3.9 MicroPort Scientific Corporation
    • 6.3.10 LivaNova PLC
    • 6.3.11 Cardinal Health (Cordis)
    • 6.3.12 B. Braun Melsungen AG
    • 6.3.13 Meril Life Sciences Pvt Ltd
    • 6.3.14 Acist Medical Systems
    • 6.3.15 Getinge AB (Maquet)
    • 6.3.16 W. L. Gore & Associates
    • 6.3.17 Johnson & Johnson (Biosense Webster)
    • 6.3.18 Teleflex

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Spain Cardiovascular Devices Market Report Scope

As per the scope of the report, cardiovascular devices are used to diagnose, monitor, and treat heart disease and related health problems. A cardiac device keeps the heart beating with a normal rhythm.

The Spain Cardiovascular Devices Market is segmented by Device Type (Diagnostic & Monitoring Devices (Electrocardiogram (ECG), Remote Cardiac Monitoring, and Other Diagnostic and Monitoring Devices) and Therapeutic & Surgical devices (Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, Stents and Grafts, Heart Valves, and Other Therapeutic and Surgical Devices)). The report offers value (in USD million) for the above segments.

By Device Diagnostic & Monitoring Devices ECG Systems
Remote Cardiac Monitor
Cardiac MRI
Cardiac CT
Echocardiography / Ultrasound
Fractional Flow Reserve (FFR) Systems
Therapeutic & Surgical Devices Coronary Stents Drug-Eluting Stents
Bare-Metal Stents
Bioresorbable Stents
Catheters PTCA Balloon Catheters
IVUS/OCT Catheters
Cardiac Rhythm Management Pacemakers
Implantable Cardioverter Defibrillators
Cardiac Resynchronization Therapy Devices
Heart Valves TAVR/TAVI
Mechanical Valves
Tissue/Bioprosthetic Valves
Ventricular Assist Devices
Artificial Hearts
Grafts & Patches
Other Cardiovascular Surgical Devices
By Indication Coronary Artery Disease
Arrhythmia
Heart Failure
Valvular Heart Disease
By End User Hospitals
Home care Settings
Others
By Device
Diagnostic & Monitoring Devices ECG Systems
Remote Cardiac Monitor
Cardiac MRI
Cardiac CT
Echocardiography / Ultrasound
Fractional Flow Reserve (FFR) Systems
Therapeutic & Surgical Devices Coronary Stents Drug-Eluting Stents
Bare-Metal Stents
Bioresorbable Stents
Catheters PTCA Balloon Catheters
IVUS/OCT Catheters
Cardiac Rhythm Management Pacemakers
Implantable Cardioverter Defibrillators
Cardiac Resynchronization Therapy Devices
Heart Valves TAVR/TAVI
Mechanical Valves
Tissue/Bioprosthetic Valves
Ventricular Assist Devices
Artificial Hearts
Grafts & Patches
Other Cardiovascular Surgical Devices
By Indication
Coronary Artery Disease
Arrhythmia
Heart Failure
Valvular Heart Disease
By End User
Hospitals
Home care Settings
Others
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current Spain cardiovascular devices market size?

The market is valued at USD 1.55 billion in 2025 and is projected to reach USD 2.01 billion by 2030.

Which segment holds the largest Spain cardiovascular devices market share?

Therapeutic and surgical devices lead with 57.20 % of 2024 revenue, driven by coronary stents and cardiac-rhythm implants.

How fast is the home-care end-user segment growing?

Home-care cardiovascular devices are forecast to expand at a 7.11 % CAGR between 2025-2030, the fastest among all end-user settings.

Why are structural-heart devices gaining momentum in Spain?

Expanded 2024 reimbursement for TAVR and TMVR doubled the eligible patient pool and boosted procedure volumes by 47 %, accelerating demand for transcatheter valve technologies.

Page last updated on: July 14, 2025

Spain Cardiovascular Devices Market Report Snapshots